NextCure Inc NXTC:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
4.88quote price arrow down-0.12 (-2.40%)
Volume
54,213
52 week range
3.25 - 9.18
Loading...
  • Open5.00
  • Day High5.00
  • Day Low4.85
  • Prev Close5.00
  • 52 Week High9.18
  • 52 Week High Date10/15/21
  • 52 Week Low3.25
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap135.42M
  • Shares Out27.75M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • YTD % Change-18.67

KEY STATS

  • Open5.00
  • Day High5.00
  • Day Low4.85
  • Prev Close5.00
  • 52 Week High9.18
  • 52 Week High Date10/15/21
  • 52 Week Low3.25
  • 52 Week Low Date05/11/22
  • Market Cap135.42M
  • Shares Out27.75M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.14
  • YTD % Change-18.67

RATIOS/PROFITABILITY

  • EPS (TTM)-2.65
  • P/E (TTM)-1.84
  • Fwd P/E (NTM)-1.77
  • EBITDA (TTM)-68.183M
  • ROE (TTM)-31.79%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-163.57%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NextCure Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel, immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology (FIND-IO), platform, the Company is studying various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to...
David Kabakoff Ph.D.
Independent Chairman of the Board
Michael Richman
President, Chief Executive Officer, Director
Timothy Mayer Ph.D.
Chief Operating Officer
Steven Cobourn CPA
Chief Financial Officer
Address
9000 Virginia Manor Rd Ste 200
Beltsville, MD
20705-4214
United States

Top Peers

SYMBOLLASTCHG%CHG
BDTX
Black Diamond Therapeutics Inc
3.69-0.17-4.40%
TCRR
TCR2 Therapeutics Inc
3.33-0.33-9.02%
INZY
Inozyme Pharma Inc
3.39-0.08-2.31%
ADVM
Adverum Biotechnologies Inc
1.35UNCHUNCH
ATOS
Atossa Therapeutics Inc
1.04-0.01-0.95%